OVERLAND PARK, Kan., Nov. 09, 2016 -- Cartesian™ (NASDAQ:CRTN), a leading provider of consulting services and managed solutions to the global telecom, media and technology industries, has reported substantial growth in the number of new regulatory-based projects. The company has secured several wins in the areas of regulatory oversight and compliance in the communications sector throughout 2016.
The competitive wins are indicative of Cartesian’s recognized expertise in this sector. For the past 25 years, Cartesian has helped regulators and communication service providers to navigate a rapidly changing environment, driven by disruptive technology and newly emerging business models. The company expects to nearly triple its regulatory-related business in 2016.
“This strong growth confirms the value that Cartesian brings to regulators,” said Michael Dargue, Principal Consultant at Cartesian. “These types of engagements not only require in-depth technical expertise but also a commercial understanding of the impacts to service providers, consumers, and other stakeholders. Our unique combination of sector focus, depth of experience, and inter-disciplinary approach to analysis, means that we provide holistic and independent input into the most important decisions regulators need to make regarding the future of the communications sector. Overall, we believe we have a solid presence in this market, and through our recognized expertise in regulatory-based work, believe we can grow this market share even further.”
About Cartesian, Inc.
Cartesian, Inc. (NASDAQ:CRTN) is a specialist provider of consulting services and managed solutions to leaders in the global communications, technology and digital media industries. Cartesian provides strategic advice, management consulting, and managed solutions to clients worldwide. The company has offices in Boston, Kansas City, London, New York, Philadelphia and Washington. For more information, visit www.cartesian.com.
Investor Contact: Matt Glover or Najim Mostamand Liolios Group, Inc. 949-574-3860 [email protected]


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



